November
12, 2007 -- 12:50pm EST
About Those Stents: Tiny Time Bombs
in Your Heart...or Not?
This morning's New York Times announces that
the drug-eluting stent has been pardoned and taken off Death Row.
In an article, titled "A
Heart Stent Gets a Reprieve From Doctors", Barnaby Feder discusses
the recent flurry of data that seems to be reversing
the year-old
panic that drug-eluting
stents (DES) were "tiny
time bombs in your heart". This phenomenon was dubbed the "firestorm
of the ESC" because the first major presentations, pointing out a
higher-than-reported incidence
of potentially
fatal
late stent
thrombosis
in DES, were made at the 2006 European Society of Cardiology (ESC)
meeting last September.
I reported on the misinformed flame-stoking press coverage
at the time, and specifically the news
report that
started off:
"Millions of Americans
could be walking around with tiny time bombs in their hearts."
In my blog entry of exactly one year ago, titled "Eentsy
Weentsy Time Bombs -- or -- The Pen is Mightier Than the Clot",
I critiqued that report and took its author to task for scaring
the hell out of patients with incorrect information.
This morning's NYT references the same report,
attributing it to "a cable news network".
In point of
fact the author, Robert Bazell, is the Emmy and Peabody awarding-winning
chief science and health correspondent
for NBC, and his report appeared on the NBC Nightly News with Brian Williams.
Bazell continued his thrust a month later in his broadcast
about the FDA stent safety panel:
"Many cardiologists
have gotten carried away with the new technology with results
that could be very
dangerous for some patients."
Or..."Watch out for that cowboy in your heart!"
The point being that much of the negative and incorrect
news coverage appeared in the broadcast and mainstream media and
had a very big impact.
As I look back and read my report from
November 21, 2006, as well as the various
DES articles we posted on Angioplasty.Org,
in light of the new data presented at this year's ESC, TCT and AHA
meetings, I have to say nothing in
my mind has changed. These stents work well, there is a very small,
but serious complication involved, strict adherence to dual antiplatelet
therapy
is critical, patient selection is extremely important (don't use
DES in patients who won't be able to comply with the Plavix/aspirin
combo and consider using a bare metal stent in situations that have
a low risk for restenosis), and statistically speaking, the small
increase in complications from DES will be offset
by the
increased restenosis seen in bare
metal stents (studies have shown that restenosis presents as a heart
attack about 1/3 of the time).
All this was known a year ago, the
new registries and studies have confirmed this knowledge.
So nothing has changed...except, oh yeah, the sales
of drug-eluting stents have slumped, down over a billion dollars
worldwide, and DES usage
in the U.S. has dropped from 90+% to low 60% range. Boston Scientific
and Cordis are laying people off and the field has been in turmoil.
Except that now multiple studies, including the oft-quoted
SCAAR
Registry from Sweden, are revising
the view that DES are dangerous. It's a billion-dollar Emily
Latella gag.
So to me, the very interesting question was one raised
by Rotterdam-based Dr. Patrick Serruys, during a panel at
the TCT last month. In referring to the 2006 ESC
presentations, he asked:
"How could such a small group of studies
by a small group of people have such a big effect on the entire
field of interventional cardiology?"
I have an answer. Tune in tomorrow....
(By the way, after I sat through almost a dozen studies
presented at TCT, all showing no difference in heart attack or death
between drug-eluting stents and bare metal stents, I asked the panel,
"So would you conclude that there's no ticking time bomb inside patients'
hearts?" And
distinguished cardiologist, Dr.
Sigmund Silber of
Munich, replied, "No. Millions of patients are walking around with
a ticking time bomb in their hearts -- it's called coronary artery
disease!")
|